Organoids Market industry Development, Trends, Analysis by 2027

the global organoids market is expected to reach US$ 3,420.40 million by 2027 from US$ 689.47 million in 2019.

According to a new market research study titled “Organoids Market Forecast to 2027 – COVID-19 Impact and Global Analysis – by Type, Application, and Source,” the global organoids market is expected to reach US$ 3,420.40 million by 2027 from US$ 689.47 million in 2019. The market is estimated to grow at a CAGR of 22.1% from 2020 to 2027. The report highlights the trends prevalent in the global organoids market and the factors driving the market along with those that act as deterrents to its growth. The market is expected to grow due to increasing demand for tumor modelling and biobanking, rising adoption of personalized drugs, and growing focus on developing alternatives for animal testing models.

Animal models are widely used in biomedical research for human-specific diseases. However, various cases demonstrate that animal models cannot always be predictive for human drug response, for instance, drug toxicology studies. This is because there are wide variations in the metabolism of drugs and toxins in humans compared to animals, which makes it nearly impossible to study drug metabolism in experimental models, such as laboratory rodent species. Additionally, in recent years, several regulations have been implemented that restrict animal use in research activities. Similarly, several bodies, such as Cruelty-Free International and the Fund for the Replacement of Animals in Medical Experiments, oppose animal-based models for research purposes.

Therefore, in order to develop alternative testing models that can provide an environment with full equivalence to the human body, various institutes are involved in developing alternative methods for drug development and biomedical research. As organoids can serve as alternatives to animal models, the current focus on reducing animal use in research is expected to support the growth of the human organoids market.


Based on type, the global organoids market is segmented into stomach, intestine, liver, pancreas, lung, brain, kidney, and others. In 2019, the intestine segment held the largest market share. This segment is also expected to dominate the market in 2027 as various experimental techniques have also been developed in parallel with, and applied to, intestinal organoid cultures with a scientifically synergistic effect. Moreover, the kidney segment is anticipated to grow at the fastest rate during the forecast period.

The emergence of coronavirus pandemic is estimated to have a significant impact on the organoids market. Majority of the pharmaceutical companies around the globe are engaged in the development of vaccine for coronavirus. Moreover, COVID-19 has also caused increased interest in human lung organoid models. However, this shift of focus is anticipated to have a positive impact on the other segments of the market. Disruptions in supply chain caused due to halt in global operations are projected to have an adverse impact on the market. 

Get Sample Copy with Complete TOC and Figures Graphs @

About Us:

The Insight Partners is a one-stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Life Science, Technology, Healthcare, Manufacturing, Automotive and Defense, Food Beverages, chemicals etc.

Contact Us:

Call: +1-646-491-9876

Email: [email protected]



soham mane

69 Blog posts